1. Pink Sheet
  2. >>Market Access

Penny-Wise Payment for Generics

Congress is cutting what the Medicaid program will pay pharmacies for generic prescriptions. Big chains warn that could mean they use brands more.

It sure seems like a funny way to try to save money on prescription drugs: try to cut spending on generics without touching what you spend on brands. But that is what Congress opted to do as part of a budget cutting measure affecting the Medicaid program that was signed into law February 8.

The new law will change how pharmacies are reimbursed for generic drugs by the state-administered Medicaid program. After extensive investigations...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from Pink Sheet

US FDA Asking Questions About Commissioner’s Voucher Program With Details Scarce

 
• By Derrick Gingery

FDA staff are trying to plan for program implementation in the absence of critical eligibility and other details, although guidance may be coming soon.

Senate Appropriators Give US FDA More Non-User Fee Funds Than House

 
• By Sarah Karlin-Smith

US FDA would receive more funding for fiscal year 2026 in the Senate appropriations bill than its House counterpart, including $10m for unannounced foreign inspections.

EU Medical Countermeasures Strategy Promises More AMR Pull Incentives

 
• By Francesca Bruce

A new EU strategy to ensure access to essential medicines will boost the development of critical medical counter measures, including vaccines and therapies, according to one pharmaceutical industry group.